Trends in Medical Use and Abuse of Opioid Analgesics

CONTEXT Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2000-04, Vol.283 (13), p.1710-1714
Hauptverfasser: Joranson, David E, Ryan, Karen M, Gilson, Aaron M, Dahl, June L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1714
container_issue 13
container_start_page 1710
container_title JAMA : the journal of the American Medical Association
container_volume 283
creator Joranson, David E
Ryan, Karen M
Gilson, Aaron M
Dahl, June L
description CONTEXT Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data) and the Automation of Reports and Consolidated Orders System (source of medical use data). PATIENTS Nationally representative sample of hospital emergency department admissions resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32,430 to 34,563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.
doi_str_mv 10.1001/jama.283.13.1710
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_211383105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>192551</ama_id><sourcerecordid>52216337</sourcerecordid><originalsourceid>FETCH-LOGICAL-a382t-b18d5010d637db6ed1debbe64c1453aa151827d3ab9beb64fbc905f223050ec63</originalsourceid><addsrcrecordid>eNpFkE1rwzAMhs3YWLtu9-0ywtg1nRTZsX0sZV_Q0Ut7DnbsDJc26eLmsH8_QzsqBJLQw4teMXaPMEUAfNmYnZkWiqaYUiJcsDEKUjkJrS7ZGECrXHLFR-wmxg2kQJLXbIQgheBajhlf9b51MQtt9uVdqM02W0efmdZlMzukrmuy5T50Ic2t2X77GOp4y64as43-7lQnbP32upp_5Ivl--d8tsgNqeKQW1ROAIIrSTpbeofOW-tLXiMXZAwKVIV0ZKy23pa8sbUG0RQFgQBflzRhT0fdfd_9DD4eqk039OmMWBWIpAhBJOjxBA12512178PO9L_Vv8cEPJ8AE5O_pjdtHeKZIyTNIWEPRyz99LzUhRBIf3rdZmY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211383105</pqid></control><display><type>article</type><title>Trends in Medical Use and Abuse of Opioid Analgesics</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Joranson, David E ; Ryan, Karen M ; Gilson, Aaron M ; Dahl, June L</creator><creatorcontrib>Joranson, David E ; Ryan, Karen M ; Gilson, Aaron M ; Dahl, June L</creatorcontrib><description>CONTEXT Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data) and the Automation of Reports and Consolidated Orders System (source of medical use data). PATIENTS Nationally representative sample of hospital emergency department admissions resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32,430 to 34,563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.283.13.1710</identifier><identifier>PMID: 10755497</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>Chicago, IL: American Medical Association</publisher><subject>Analgesics ; Analgesics, Opioid - therapeutic use ; Biological and medical sciences ; Drug abuse ; Drug Utilization - trends ; Fentanyl - therapeutic use ; Humans ; Hydromorphone - therapeutic use ; Medical sciences ; Meperidine - therapeutic use ; Morphine - therapeutic use ; Narcotics ; Neuropharmacology ; Opioid-Related Disorders - epidemiology ; Oxycodone - therapeutic use ; Pain - drug therapy ; Pharmacology. Drug treatments ; Retrospective Studies ; Risk Assessment ; Social Change ; Trends ; United States - epidemiology</subject><ispartof>JAMA : the journal of the American Medical Association, 2000-04, Vol.283 (13), p.1710-1714</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright American Medical Association Apr 5, 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a382t-b18d5010d637db6ed1debbe64c1453aa151827d3ab9beb64fbc905f223050ec63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.283.13.1710$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.283.13.1710$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,315,782,786,3344,27933,27934,76499,76502</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1313940$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10755497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joranson, David E</creatorcontrib><creatorcontrib>Ryan, Karen M</creatorcontrib><creatorcontrib>Gilson, Aaron M</creatorcontrib><creatorcontrib>Dahl, June L</creatorcontrib><title>Trends in Medical Use and Abuse of Opioid Analgesics</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>CONTEXT Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data) and the Automation of Reports and Consolidated Orders System (source of medical use data). PATIENTS Nationally representative sample of hospital emergency department admissions resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32,430 to 34,563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.</description><subject>Analgesics</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Drug abuse</subject><subject>Drug Utilization - trends</subject><subject>Fentanyl - therapeutic use</subject><subject>Humans</subject><subject>Hydromorphone - therapeutic use</subject><subject>Medical sciences</subject><subject>Meperidine - therapeutic use</subject><subject>Morphine - therapeutic use</subject><subject>Narcotics</subject><subject>Neuropharmacology</subject><subject>Opioid-Related Disorders - epidemiology</subject><subject>Oxycodone - therapeutic use</subject><subject>Pain - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Social Change</subject><subject>Trends</subject><subject>United States - epidemiology</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1rwzAMhs3YWLtu9-0ywtg1nRTZsX0sZV_Q0Ut7DnbsDJc26eLmsH8_QzsqBJLQw4teMXaPMEUAfNmYnZkWiqaYUiJcsDEKUjkJrS7ZGECrXHLFR-wmxg2kQJLXbIQgheBajhlf9b51MQtt9uVdqM02W0efmdZlMzukrmuy5T50Ic2t2X77GOp4y64as43-7lQnbP32upp_5Ivl--d8tsgNqeKQW1ROAIIrSTpbeofOW-tLXiMXZAwKVIV0ZKy23pa8sbUG0RQFgQBflzRhT0fdfd_9DD4eqk039OmMWBWIpAhBJOjxBA12512178PO9L_Vv8cEPJ8AE5O_pjdtHeKZIyTNIWEPRyz99LzUhRBIf3rdZmY</recordid><startdate>20000405</startdate><enddate>20000405</enddate><creator>Joranson, David E</creator><creator>Ryan, Karen M</creator><creator>Gilson, Aaron M</creator><creator>Dahl, June L</creator><general>American Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20000405</creationdate><title>Trends in Medical Use and Abuse of Opioid Analgesics</title><author>Joranson, David E ; Ryan, Karen M ; Gilson, Aaron M ; Dahl, June L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a382t-b18d5010d637db6ed1debbe64c1453aa151827d3ab9beb64fbc905f223050ec63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Analgesics</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Drug abuse</topic><topic>Drug Utilization - trends</topic><topic>Fentanyl - therapeutic use</topic><topic>Humans</topic><topic>Hydromorphone - therapeutic use</topic><topic>Medical sciences</topic><topic>Meperidine - therapeutic use</topic><topic>Morphine - therapeutic use</topic><topic>Narcotics</topic><topic>Neuropharmacology</topic><topic>Opioid-Related Disorders - epidemiology</topic><topic>Oxycodone - therapeutic use</topic><topic>Pain - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Social Change</topic><topic>Trends</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joranson, David E</creatorcontrib><creatorcontrib>Ryan, Karen M</creatorcontrib><creatorcontrib>Gilson, Aaron M</creatorcontrib><creatorcontrib>Dahl, June L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joranson, David E</au><au>Ryan, Karen M</au><au>Gilson, Aaron M</au><au>Dahl, June L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in Medical Use and Abuse of Opioid Analgesics</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2000-04-05</date><risdate>2000</risdate><volume>283</volume><issue>13</issue><spage>1710</spage><epage>1714</epage><pages>1710-1714</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>CONTEXT Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs. OBJECTIVE To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND SETTING Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data) and the Automation of Reports and Consolidated Orders System (source of medical use data). PATIENTS Nationally representative sample of hospital emergency department admissions resulting from drug abuse. MAIN OUTCOME MEASURES Medical use in grams and grams per 100,000 population and mentions of drug abuse by number and percentage of the population. RESULTS From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32,430 to 34,563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865). CONCLUSIONS The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.</abstract><cop>Chicago, IL</cop><pub>American Medical Association</pub><pmid>10755497</pmid><doi>10.1001/jama.283.13.1710</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2000-04, Vol.283 (13), p.1710-1714
issn 0098-7484
1538-3598
language eng
recordid cdi_proquest_journals_211383105
source MEDLINE; American Medical Association Journals
subjects Analgesics
Analgesics, Opioid - therapeutic use
Biological and medical sciences
Drug abuse
Drug Utilization - trends
Fentanyl - therapeutic use
Humans
Hydromorphone - therapeutic use
Medical sciences
Meperidine - therapeutic use
Morphine - therapeutic use
Narcotics
Neuropharmacology
Opioid-Related Disorders - epidemiology
Oxycodone - therapeutic use
Pain - drug therapy
Pharmacology. Drug treatments
Retrospective Studies
Risk Assessment
Social Change
Trends
United States - epidemiology
title Trends in Medical Use and Abuse of Opioid Analgesics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T01%3A57%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20Medical%20Use%20and%20Abuse%20of%20Opioid%20Analgesics&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Joranson,%20David%20E&rft.date=2000-04-05&rft.volume=283&rft.issue=13&rft.spage=1710&rft.epage=1714&rft.pages=1710-1714&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.283.13.1710&rft_dat=%3Cproquest_pubme%3E52216337%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211383105&rft_id=info:pmid/10755497&rft_ama_id=192551&rfr_iscdi=true